Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/risk-of-cardiovascular-outcomes-and-antihypertensive-triple-00eoTT0lxm
References (68)
-
K. Pantalone, T. Hobbs, B. Wells, S. Kong, M. Kattan, J. Bouchard, Changhong Yu, B. Sakurada, A. Milinovich, W. Weng, J. Bauman, R. Zimmerman (2015)
Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health systemBMJ Open Diabetes Research & Care, 3
-
B. Babitsch, D. Gohl, T. Lengerke (2012)
Re-revisiting Andersen’s Behavioral Model of Health Services Use: a systematic review of studies from 1998–2011GMS Psycho-Social-Medicine, 9
-
S. Inouye, Ying Zhang, Richard Jones, Peilin Shi, L. Cupples, Harold Calderon, Edward Marcantonio (2008)
Risk Factors for Hospitalization Among Community-Dwelling Primary Care Older Patients: Development and Validation of a Predictive ModelMedical Care, 46
-
H. Morris (2014)
Standards of Medical Care in Diabetes -
Weiyi Yang, Joanne Chang, K. Kahler, Thomas Fellers, J. Orloff, E. Wu, A. Bensimon (2010)
Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensivesCurrent Medical Research and Opinion, 26
-
World Health O: Global Health Observatory (GHO) Data: Raised Blood Pressure -
(2015)
CDC: Underlying Cause of Death 1999-2013 on CDC WONDER Online Database -
L. Osterberg, T. Blaschke (2005)
Adherence to medication.The New England journal of medicine, 353 5
-
Amlodipine/aliskiren/hydrochlorothiazide (Amturnide) -
R. Vasan, A. Beiser, S. Seshadri, M. Larson, W. Kannel, R. D'Agostino, D. Levy (2002)
Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.JAMA, 287 8
-
V. Visco, R. Finelli, A. Pascale, Rocco Giannotti, D. Fabbricatore, N. Ragosa, M. Ciccarelli, Guido Iaccarino (2017)
Larger Blood Pressure Reduction by Fixed-Dose Compared to Free Dose Combination Therapy of ACE Inhibitor and Calcium Antagonist in Hypertensive PatientsTranslational Medicine @ UniSa, 16
-
P. Ho, J. Spertus, F. Masoudi, K. Reid, E. Peterson, D. Magid, H. Krumholz, John Rumsfeld (2006)
Impact of medication therapy discontinuation on mortality after myocardial infarction.Archives of internal medicine, 166 17
-
Marie-Isabel Murray, K. Bode, P. Whittaker (2019)
Gender-specific associations between coronary heart disease and other chronic diseases: cross-sectional evaluation of national survey data from adult residents of GermanyJournal of Geriatric Cardiology : JGC, 16
-
J. Rasmussen, A. Chong, D. Alter (2007)
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction.JAMA, 297 2
-
Triamterene/hydrochlorothiazide (Dyazide, Maxzide) Methyldopa/hydrochlorothiazide -
A. Culyer (2014)
Medicare Advantage Plans -
S. Loon, Jing Jin, Miao Goh (2015)
The Relationship Between Quality of Life and Adherence to Medication in Glaucoma Patients in SingaporeJournal of Glaucoma, 24
-
A. Möller-Leimkühler (2007)
Gender differences in cardiovascular disease and comorbid depression.Dialogues in Clinical Neuroscience, 9
-
Tatiana Nwankwo, S. Yoon, V. Burt, Quiping Gu (2013)
Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012.NCHS data brief, 133
-
B. Neal, S. MacMahon, N. Chapman (2000)
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trialsThe Lancet, 356
-
P. James, S. Oparil, B. Carter, W. Cushman, C. Dennison-Himmelfarb, J. Handler, D. Lackland, M. LeFevre, T. Mackenzie, O. Ogedegbe, Sidney Smith, L. Svetkey, S. Taler, R. Townsend, J. Wright, A. Narva, E. Ortiz (2012)
Evidence-Based Guideline for the Management of High Blood Pressure in AdultsJAMA, 1097
-
D. Baker, J. Gazmararian, Mark Williams, Tracy Scott, R. Parker, D. Green, Junling Ren, J. Peel (2002)
Functional health literacy and the risk of hospital admission among Medicare managed care enrollees.American journal of public health, 92 8
-
T. Stanton, J. Reid (2002)
Fixed dose combination therapy in the treatment of hypertensionJournal of Human Hypertension, 16
-
W. Elliott (2010)
Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 TrialsYearbook of Cardiology, 2010
-
M. DiMatteo, Patrick Giordani, H. Lepper, T. Croghan (2002)
Patient Adherence and Medical Treatment Outcomes: A Meta-AnalysisMedical Care, 40
-
L. Ogden, Jiang He, E. Lydick, P. Whelton (2000)
Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification.Hypertension, 35 2
-
D. Mozaffarian, E. Benjamin, A. Go, D. Arnett, M. Blaha, M. Cushman, S. Ferranti, J. Despres, H. Fullerton, V. Howard, Mark Huffman, S. Judd, B. Kissela, D. Lackland, J. Lichtman, L. Lisabeth, Simin Liu, R. Mackey, D. Matchar, Darren Mcguire, E. Mohler, C. Moy, P. Muntner, M. Mussolino, K. Nasir, R. Neumar, G. Nichol, L. Palaniappan, D. Pandey, M. Reeves, C. Rodriguez, P. Sorlie, J. Stein, A. Towfighi, T. Turan, S. Virani, J. Willey, D. Woo, R. Yeh, M. Turner (2009)
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart AssociationCirculation, 131
-
Guideline for High Blood Pressure -
S. Julius, S. Kjeldsen, M. Weber, H. Brunner, S. Ekman, L. Hansson, T. Hua, J. Laragh, G. Mcinnes, Lada Mitchell, F. Plat, A. Schork, Beverly Smith, A. Zanchetti (2004)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trialThe Lancet, 363
-
Vittorio Basevi (2011)
Standards of Medical Care in Diabetes—2012Diabetes Care, 35
-
D. Power (2006)
Standards of Medical Care in Diabetes: Response to position statement of the American Diabetes AssociationDiabetes Care, 29
-
S. Bangalore, G. Kamalakkannan, S. Parkar, F. Messerli (2007)
Fixed-dose combinations improve medication compliance: a meta-analysis.The American journal of medicine, 120 8
-
M. Cavender, P. Steg, Sidney Smith, K. Eagle, E. Ohman, S. Goto, J. Kuder, K. Im, P. Wilson, Deepak Bhatt (2015)
Impact of Diabetes on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years from the REACH RegistryCirculation
-
M. Eisner, P. Katz, E. Yelin, S. Shiboski, P. Blanc (2000)
Risk factors for hospitalization among adults with asthma: the influence of sociodemographic factors and asthma severityRespiratory Research, 2
-
B. Stults, Robert Jones (2006)
Management of Hypertension in DiabetesDiabetes Spectrum, 19
-
K. Humphries, M. Izadnegahdar, T. Sedlak, J. Saw, N. Johnston, K. Schenck-Gustafsson, R. Shah, V. Regitz-Zagrosek, J. Grewal, V. Vaccarino, Janet Wei, C. Merz (2017)
Sex differences in cardiovascular disease – Impact on care and outcomesFrontiers in Neuroendocrinology, 46
-
ACEI angiotensin-converting-enzyme inhibitor, ARB angiotensin receptor blocker -
J. Redón, M. Tellez-Plaza, D. Orozco-Beltrán, V. Gil-Guillén, S. Fernández, J. Navarro-Pérez, V. Pallarés, F. Valls, Antonio Fernandez, A. Perez-Navarro, C. Sánchis, A. Dominguez-lucas, G. Sanz, J. Martin-Moreno (2016)
Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk studyJournal of Hypertension, 34
-
N. Bello, B. Claggett, Akshay Desai, J. McMurray, C. Granger, S. Yusuf, K. Swedberg, M. Pfeffer, S. Solomon (2014)
Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection FractionCirculation: Heart Failure, 7
-
K. Bahadori, J. FitzGerald, M. Fitzgerald (2007)
Risk factors of hospitalization and readmission of patients with COPD exacerbation – systematic reviewInternational Journal of Chronic Obstructive Pulmonary Disease, 2
-
P. James, S. Oparil, B. Carter, W. Cushman, C. Dennison-Himmelfarb, J. Handler, D. Lackland, M. LeFevre, T. Mackenzie, O. Ogedegbe, Sidney Smith, L. Svetkey, S. Taler, R. Townsend, J. Wright, A. Narva, E. Ortiz (2014)
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).JAMA, 311 5
-
E. MacLaughlin, C. Raehl, Angela Treadway, Teresa Sterling, Dennis Zoller, C. Bond (2005)
Assessing Medication Adherence in the ElderlyDrugs & Aging, 22
-
Ram Cv (2013)
Fixed-dose triple-combination treatments in the management of hypertension.Managed care (Langhorne, Pa.), 22
-
A. Chamberlain, K. Vickers, R. Colligan, S. Weston, T. Rummans, V. Roger (2011)
Associations of preexisting depression and anxiety with hospitalization in patients with cardiovascular disease.Mayo Clinic proceedings, 86 11
-
A. Mazza, S. Lenti, L. Schiavon, A. Sacco, F. Dell’avvocata, G. Rigatelli, E. Ramazzina (2017)
Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical PracticeAdvances in Therapy, 34
-
Jianhui Hu, Meredith Gonsahn, D. Nerenz (2014)
Socioeconomic status and readmissions: evidence from an urban teaching hospital.Health affairs, 33 5
-
B. Neupane, M. Jerrett, R. Burnett, T. Marrie, A. Arain, M. Loeb (2010)
Long-term exposure to ambient air pollution and risk of hospitalization with community-acquired pneumonia in older adults.American journal of respiratory and critical care medicine, 181 1
-
J. Spence, L. Pilote (2015)
Importance of sex and gender in atherosclerosis and cardiovascular disease.Atherosclerosis, 241 1
-
Gender in Cardiovascular Diseases -
Quanhe Yang, Anping Chang, M. Ritchey, Fleetwood Loustalot (2017)
Antihypertensive Medication Adherence and Risk of Cardiovascular Disease Among Older Adults: A Population‐Based Cohort StudyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 6
-
B. Epstein, Niren Shah, N. Borja‐Hart (2013)
Management of hypertension with fixed-dose triple-combination treatmentsTherapeutic Advances in Cardiovascular Disease, 7
-
P. Verdecchia, G. Gentile, F. Angeli, G. Mazzotta, G. Mancia, G. Reboldi (2010)
Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trialsJournal of Hypertension, 28
-
Benjamin Gallagher, P. Muntner, Nathalie Moise, Jenny Lin, I. Kronish (2015)
Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence?Journal of Hypertension, 33
-
JP Mortola, EL Seifert (2001)
Information processing at the nucleus tractus solitarii and respiratory rhythm generationRespiratory Research, 2
-
C. Ram (2013)
Fixed-dose triple-combination treatments in the management of hypertension.Managed care, 22 12
-
C. Arauz-Pacheco, Marian Parrott, P. Raskin (2002)
The treatment of hypertension in adult patients with diabetes.Diabetes care, 25 1
-
G. Yan, Keith Norris, T. Greene, Alison Yu, Jennie Ma, Wei Yu, A. Cheung (2014)
Race/ethnicity, age, and risk of hospital admission and length of stay during the first year of maintenance hemodialysis.Clinical journal of the American Society of Nephrology : CJASN, 9 8
-
N. Bello, B. Claggett, Akshay Desai, C. Granger, S. Yusuf, K. Swedberg, M. Pfeffer, S. Solomon (2017)
Influence of Prior Heart Failure Hospitalization on Cardiovascular Events in Patients with Reduced and Preserved Ejection Fraction Bello et al: Effect of HF Hospitalization on CV Events -
J. Staessen, L. Thijs, R. Fagard, H. Celis, W. Birkenhäger, C. Bulpitt, P. Leeuw, A. Fletcher, F. Forette, G. Leonetti, P. McCormack, C. Nachev, E. O’Brien, J. Rodicio, J. Rosenfeld, C. Sarti, J. Tuomilehto, J. Webster, Y. Yodfat, A. Zanchetti (2004)
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe TrialJournal of Hypertension, 22
-
A. Hyre, M. Krousel‐Wood, P. Muntner, L. Kawasaki, K. Desalvo (2007)
Prevalence and Predictors of Poor Antihypertensive Medication Adherence in an Urban Health Clinic SettingThe Journal of Clinical Hypertension, 9
-
(2015)
HEART ORG/ Condi tions /More/Diabe tes/WhyDi abete sMatt ers/Cardi ovasc ular-Disea se-Diabe tes_UCM_31386 5_Artic le.jsp/#.WaY2-K2ZOC Q -
D. Brixner, Kenneth II, X. Sheng, R. Nelson, A. Keskinaslan (2008)
Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations*Current Medical Research and Opinion, 24
-
B. Vrijens, G. Vincze, P. Kristanto, J. Urquhart, M. Burnier (2008)
Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing historiesBMJ : British Medical Journal, 336
-
N. Sood, Kurt Reinhart, W. Baker (2010)
Combination therapy for the management of hypertension: A review of the evidence.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 67 11
-
Heshmatollah Heydari, Kamran A, S. Ahari, Malepour A, H. h (2014)
Determinants of Patient's Adherence to Hypertension Medications: Application of Health Belief Model Among Rural PatientsAnnals of Medical and Health Sciences Research, 4
-
A. Deshpande, M. Harris-Hayes, M. Schootman (2008)
Epidemiology of Diabetes and Diabetes-Related ComplicationsPhysical Therapy, 88
-
L. Kennedy (2007)
Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes MellitusYearbook of Endocrinology, 2007
-
P. Ho, C. Bryson, J. Rumsfeld (2009)
Medication Adherence: Its Importance in Cardiovascular OutcomesCirculation, 119
- Publisher
- Springer Journals
- Copyright
- Copyright © Springer Nature Switzerland AG 2020
- ISSN
- 1175-3277
- eISSN
- 1179-187X
- DOI
- 10.1007/s40256-020-00395-0
- Publisher site
- See Article on Publisher Site
Abstract
ObjectivesThe aim was to evaluate the risk of cardiovascular-specific hospitalizations with different types of antihypertensive triple combination therapy among patients enrolled in a Medicare Advantage Plan (MAP).MethodsA retrospective cohort study was conducted among patients with hypertension enrolled in a Texas MAP between January 2014 and December 2016. Antihypertensive combination therapy users were classified into three treatment groups: single-pill triple combination, fixed-dose dual combination plus a third agent, and free triple combination. Group differences were assessed using Chi-square tests for binary variables and Student’s t tests for continuous variables. Cox proportional hazards model was performed to assess the association between type of combination therapy and risk of cardiovascular-specific hospitalization adjusting for potential confounders.ResultsA total of 10,836 triple combination users were identified. The risk of cardiovascular disease (CVD) hospitalization for the fixed-dose dual combination plus a third agent group [hazard ratio (HR) 3.82, 95% confidence interval (CI) 1.80–8.12] and for the free triple combination therapy group (HR 3.65, 95% CI 1.43–9.31) was significantly higher than for the single-pill triple combination group.ConclusionSingle-pill triple combination therapy was significantly associated with a lower risk of CVD hospitalizations in comparison to other types of triple combination therapy.
Journal
American Journal of Cardiovascular Drugs – Springer Journals
Published: Feb 11, 2020